Interleukin-6 as prognosticator in patients with COVID-19

被引:139
|
作者
Grifoni, Elisa [1 ]
Valoriani, Alice [2 ]
Cei, Francesco [2 ]
Lamanna, Roberta [3 ]
Gelli, Anna Maria Grazia [3 ]
Ciambotti, Benedetta [3 ]
Vannucchi, Vieri [4 ]
Moroni, Federico [4 ]
Pelagatti, Lorenzo [4 ]
Tarquini, Roberto [2 ]
Landini, Giancarlo [3 ]
Vanni, Simone [5 ]
Masotti, Luca [1 ]
机构
[1] San Giuseppe Hosp, Internal Med 2, Viale Boccaccio 20, I-50053 Florence, Italy
[2] San Giuseppe Hosp, Internal Med 1, Empoli, Italy
[3] San Giuseppe Hosp, Clin Pathol, Lab Dept, Empoli, Italy
[4] Santa Maria Nuova Hosp, Internal Med, Florence, Italy
[5] San Giuseppe Hosp, Emergency Dept, Empoli, Italy
关键词
D O I
10.1016/j.jinf.2020.06.008
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:466 / 467
页数:2
相关论文
共 50 条
  • [31] Genetic Regulation of Interleukin-6 and Interleukin-10 in COVID-19 Infection
    Rostami-Far, Zahra
    Rahmani, Khaled
    Mansouri, Kamran
    Erfan, Mohammad Bagher Khadem
    Shaveisi-Zadeh, Farhad
    Nikkhoo, Bahram
    REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2023, 12 (02): : 284 - 293
  • [32] The association of interleukin-6 value, interleukin inhibitors, and outcomes of patients with COVID-19 in New York City
    Maeda, Tetsuro
    Obata, Reiichiro
    Rizk, Dahlia D. O.
    Kuno, Toshiki
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 463 - 471
  • [33] Prognostic value of interleukin-6, C -reactive protein, patients with COVID-19 and procalcitonin in
    Liu, Fang
    Li, Lin
    Xu, MengDa
    Wu, Juan
    Luo, Ding
    Zhu, YuSi
    Li, BiXi
    Song, XiaoYang
    Zhou, Xiang
    JOURNAL OF CLINICAL VIROLOGY, 2020, 127
  • [34] Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context
    Angriman, Federico
    Ferreyro, Bruno L.
    Burry, Lisa
    Fan, Eddy
    Ferguson, Niall D.
    Husain, Shahid
    Keshavjee, Shaf H.
    Lupia, Enrico
    Munshi, Laveena
    Renzi, Samuele
    Ubaldo, Onion Gerald, V
    Rochwerg, Bram
    Del Sorbo, Lorenzo
    LANCET RESPIRATORY MEDICINE, 2021, 9 (06): : 655 - 664
  • [35] Interleukin-6 added to CALL score better predicts the prognosis of COVID-19 patients
    Grifoni, Elisa
    Vannucchi, Vieri
    Valoriani, Alice
    Cei, Francesco
    Lamanna, Roberta
    Gelli, Anna Maria Grazia
    Ciambotti, Benedetta
    Moroni, Federico
    Pelagatti, Lorenzo
    Tarquini, Roberto
    Landini, Giancarlo
    Vanni, Simone
    Masotti, Luca
    INTERNAL MEDICINE JOURNAL, 2021, 51 (01) : 146 - 147
  • [36] Interleukin-6 as unfavorable prognostic factor in patients affected by Covid-19 and hip fracture
    Pantalone, A.
    Bruni, D.
    Pantalone, P.
    Buda, R.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (01): : 353 - 354
  • [37] Can aldosterone increase interleukin-6 levels in Covid-19 pneumonia?
    Campana, Pasquale
    Flocco, Veronica
    Aruta, Francesco
    Cacciatore, Francesco
    Abete, Pasquale
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 622 - 623
  • [38] Moving to the Head of the "Claza"-Targeting Interleukin-6 for COVID-19 Pneumonia
    Shaver, Ciara M.
    CRITICAL CARE MEDICINE, 2022, 50 (09) : 1406 - 1408
  • [39] Interleukin-6 in Covid-19: A systematic review andmeta-analysis
    Coomes, Eric A.
    Haghbayan, Hourmazd
    REVIEWS IN MEDICAL VIROLOGY, 2020, 30 (06) : 1 - 9
  • [40] Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome
    Chen, Luke Y. C.
    Biggs, Catherine M.
    Jamal, Shahin
    Stukas, Sophie
    Wellington, Cheryl L.
    Sekhon, Mypinder S.
    CELL REPORTS MEDICINE, 2021, 2 (05)